Français
ItalianoBond Novartis AG 4.4% ( US66989HBG20 ) in USD
| Issuer | Novartis AG | ||||
| Market price |  100.00 % ▲ |
||||
| Country |  Switzerland
|
||||
| ISIN code |
 US66989HBG20 ( in USD )
|
||||
| Interest rate | 4.4% per year ( payment 2 times a year) | ||||
| Maturity | 17/03/2031 | ||||
|
Prospectus brochure in PDF format |
|||||
| Minimal amount | / | ||||
| Total amount | / | ||||
| Cusip | 66989HBG2 | ||||
| Standard & Poor's ( S&P ) rating | AA- ( High grade - Investment-grade ) | ||||
| Moody's rating | Aa3 ( High grade - Investment-grade ) | ||||
| Next Coupon | 18/09/2026 ( In 23 days ) | ||||
| Detailed description |
Novartis AG is a Swiss multinational pharmaceutical company that researches, develops, manufactures, and markets a broad range of innovative medicines and healthcare solutions globally. The Bond issued by Novartis AG ( Switzerland ) , in USD, with the ISIN code US66989HBG20, pays a coupon of 4.4% per year. The coupons are paid 2 times per year and the Bond maturity is 17/03/2031 The Bond issued by Novartis AG ( Switzerland ) , in USD, with the ISIN code US66989HBG20, was rated Aa3 ( High grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Novartis AG ( Switzerland ) , in USD, with the ISIN code US66989HBG20, was rated AA- ( High grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||
| |||||